A novel, selective and orally-available glucosylceramide synthase inhibitor for substrate reduction therapy of Fabry disease

Details

Language :

English

ISSN :

10967192

Volume :

108

Issue :

2

Database :

Academic Search Index

Journal :

Molecular Genetics & Metabolism

Publication Type :

Academic Journal

Accession number :

85156252

Full Text :

https://doi.org/10.1016/j.ymgme.2012.11.026